LeMaitre Vascular, Inc. (LMAT) Stock Analysis — Probabli.AI
AI-powered analysis for LMAT (LeMaitre Vascular, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $109.87 · Market cap: $2.5B · AI outlook: Bullish
LeMaitre Vascular demonstrates rapid revenue and product innovation-driven growth, coupled with strategic acquisitions and healthy fundamentals. While competition and regulatory concerns remain, the overall trajectory suggests above-market performance with significant long-term potential. Analysts maintain a favorable outlook.
Probabilistic 1-Year Outlook
- Bull 45% · Neutral 40% · Bear 15%
- 1-year price estimates — P10: $95 / P50: $125 / P90: $140
- The company has shown strong revenue growth and industry expansion with innovative products. However, there are risks associated with competition and regulatory scrutiny.
5-Year Outlook
- Bull 55% · Neutral 30% · Bear 15%
- 5-year price estimates — P10: $90 / P50: $190 / P90: $250
SWOT Highlights
- Strength: Rapid revenue growth
- Strength: Innovative, market-transforming product launches
- Risk: Relatively high valuation metrics compared to peers
- Risk: Limited dividend income for investors
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
5 Wall Street analysts rate LMAT a BUY with a mean price target of $105.8. LeMaitre Vascular, Inc. currently pays a dividend with a yield of approximately 0.91%.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
LMAT forecast details · LMAT sentiment details · LMAT insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.